Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Author links open overlay panelAvrahamKarasik1StefanieLanzinger23Elise Chia-HuiTan4DaisukeYabe5678Dae JungKim9Wayne H-HSheu10CheliMelzer-Cohen1Reinhard W.Holl2Kyoung HwaHa9KamleshKhunti11FrancescoZaccardi11AnuradhaaSubramanian12KrishnarajahNirantharakumar121314ThomasNyström15LeoNiskanen16Majken LinnemannJensen17FabianHoti18RihoKlement19AnoukDéruaz-Luyet20Moe H.Kyaw21…JúlioNúñez28
留言 (0)